Full Text View
Tabular View
No Study Results Posted
Related Studies
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
This study is currently recruiting participants.
Verified May 2012 by Nathan Kline Institute for Psychiatric Research
Study NCT00802919   Information provided by Nathan Kline Institute for Psychiatric Research

First Received on December 4, 2008.   Last Updated on May 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Cigarette Smoking
Additional conditions recognized in this trial
Smoking
More general conditions related to this trial
Habits
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Varenicline
Placebo for varenicline
More general drug interventions related to this trial
Cholinergic Agents
Cholinergic Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Nathan Kline Institute for Psychiatric Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services